Trials / Sponsors / Tianhong Li
Tianhong Li
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Adenocarcinoma, Advanced Malignant Solid Neoplasm, Metastatic Adenocarcinoma | Phase 1 / Phase 2 | 2021-10-13 |
| Terminated | CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | 2020-10-30 |